共 22 条
[1]
Ran domized phaseⅢintergrouptrialofisotretinointopreventsecondprimarytumorsinstageⅠnon small celllungcancer. LippmanSM,LeeJJ,KarpDD ,etal. JNatlCancerInst . 2001
[2]
Immunogenicity of a fucosylGM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer. Dickler MN, Ragupathi G, Liu NX, et al. Clinical Cancer Research . 1999
[3]
PhaseⅠandpharmacokineticstudyoffarnesylpro teintransferaseinhibitorR115777inad vancedcancer. ZujewskiJ,HorakID,BolCJ,etal. JClinOncol . 2000
[4]
Mul ti institutional phaseⅠ/Ⅱtrialoforalbexaroteneincombinationwithcisplatinandvinorelbinein previouslyuntreatedpatientswithadvancednon small celllungcancer. KhuriFR,RigasJR,FiglinRA ,etal. JClinOncol . 2001
[5]
Placebo controlledtrialofbexarotene,aretinoidxreceptoragonist,asmaintenancetherapyforpatientstreatedwithchemothera pyforadvancednon small celllungcancer. RizviN,HawkinsMJ,EisenbergPD ,etal. ClinLungCancer . 2001
[6]
Ob jectiveregressionsinnon smallcelllungcan cerpatientstreatedinphaseⅠtrailsoforalZD 1839 (Iressa),aselectivetyrosinekinaseinhibitorthatblockstheepidermalgrowthfactorreceptor (EGFR ). KrisMG,HerbstR,RischinD ,etal. Lung Cancer . 2000
[7]
Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas. Achiwa H, Yatabe Y, Hida T, et al. Clinical Cancer Research . 1999
[8]
On receptor inhibitors and chemotherapy. Ryan PD,Chabner BA. Clinical Cancer Research . 2000
[9]
AphaseⅠ/ⅡstudyofautologousGM CSFgene modifiedcancervaccinesinsubjectswithnon smallcelllungcancer. NemunmtlsJ,StermanD,JablonsD ,etal. ProcAmSocClinOncol . 2001
[10]
PhaseⅠtrialofadenovirusp53inbronchi oloalveolarcelllungcarcinoma (BAC)ad ministeredbybronchoalveolarlavage. KubbaSM,AdakSM,SchillerJ,etal. ProcAmSocClinOncol . 2000